IE39869B1 - 2-(1'-piperazinyl)-quinoxaline compounds having pharmaceutical activity - Google Patents

2-(1'-piperazinyl)-quinoxaline compounds having pharmaceutical activity

Info

Publication number
IE39869B1
IE39869B1 IE1397/74A IE139774A IE39869B1 IE 39869 B1 IE39869 B1 IE 39869B1 IE 1397/74 A IE1397/74 A IE 1397/74A IE 139774 A IE139774 A IE 139774A IE 39869 B1 IE39869 B1 IE 39869B1
Authority
IE
Ireland
Prior art keywords
alkyl
hydrogen
alkanoyl
carbamoyl
alkoxycarbonyl
Prior art date
Application number
IE1397/74A
Other languages
English (en)
Other versions
IE39869L (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IE39869L publication Critical patent/IE39869L/xx
Publication of IE39869B1 publication Critical patent/IE39869B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IE1397/74A 1973-07-13 1974-07-02 2-(1'-piperazinyl)-quinoxaline compounds having pharmaceutical activity IE39869B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37902273A 1973-07-13 1973-07-13
US46538174A 1974-04-29 1974-04-29

Publications (2)

Publication Number Publication Date
IE39869L IE39869L (en) 1975-01-13
IE39869B1 true IE39869B1 (en) 1979-01-17

Family

ID=27008442

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1397/74A IE39869B1 (en) 1973-07-13 1974-07-02 2-(1'-piperazinyl)-quinoxaline compounds having pharmaceutical activity

Country Status (18)

Country Link
JP (1) JPS5037791A (fr)
AU (1) AU7073174A (fr)
BG (1) BG21606A3 (fr)
CH (1) CH605919A5 (fr)
DD (1) DD112127A5 (fr)
DE (1) DE2433397A1 (fr)
DK (1) DK342674A (fr)
ES (1) ES428107A1 (fr)
FI (1) FI193974A (fr)
FR (1) FR2236499B1 (fr)
GB (1) GB1440722A (fr)
IE (1) IE39869B1 (fr)
IL (1) IL45158A0 (fr)
LU (1) LU70510A1 (fr)
NL (1) NL7408705A (fr)
NO (1) NO742351L (fr)
RO (1) RO63539A (fr)
SE (1) SE417316B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082845A (en) * 1977-04-25 1978-04-04 Merck & Co., Inc. 3-(1-Piperazinyl)-pyrido[2,3-b]pyrazines
US4091098A (en) * 1977-04-25 1978-05-23 Merck & Co., Inc. 3-(1-PIPERAZINYL)-1,2,4-BENZOTRIAZINES AND N-oxides
US4107309A (en) * 1977-05-23 1978-08-15 American Cyanamid Company Substituted imidazo[1,2-d]-as-triazines
US4091101A (en) * 1977-06-15 1978-05-23 Merck & Co., Inc. 6-(1-Piperazinyl)quinoxaline
EP0094498A3 (fr) * 1982-05-06 1985-04-03 American Cyanamid Company Dérivés de 1-pipérazine utiles contre l'arthériosclérose
ES2042395B1 (es) * 1992-02-27 1994-06-16 Promotora Catalana De Inversio Procedimiento para la obtencion de derivados de 2-ciano-3-piperacinilquinoxalinas.
FR2731221B1 (fr) * 1995-03-01 1997-05-30 Pf Medicament Nouveaux derives de l'ethyl-1 dihydro-1, 2 oxo-2 methylamino-3 quinoxaline, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
WO1999021850A1 (fr) * 1997-10-24 1999-05-06 Neurogen Corporation Piperazines de 1-(2-naphtyle) et de 1-(2-azanaphtyle)-4-(1-phenylmethyle)en tant que ligands pour le sous-type du recepteur de la dopamine d¿4?
US6040448A (en) 1997-10-24 2000-03-21 Neurogen Corporation Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands
WO2000012500A2 (fr) * 1998-09-02 2000-03-09 Neurogen Corporation 2-aryl-4-[4-heteroaryl]piperazin-1-yl methylimidazoles: ligands pour le sous-type de recepteur d4 de la dopamine
SE9901884D0 (sv) * 1999-05-21 1999-05-21 Pharmacia & Upjohn Ab Novel compounds their use and preparation
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
WO2000076984A2 (fr) * 1999-05-21 2000-12-21 Biovitrum Ab Nouveaux composes, et utilisation et preparation de ces derniers
JP4707261B2 (ja) * 2001-05-15 2011-06-22 日本エンバイロケミカルズ株式会社 キノキサリン系化合物および工業用殺菌組成物
ATE454383T1 (de) 2002-06-19 2010-01-15 Biovitrum Ab Publ Neue verbindungen, deren verwendung und herstellung
WO2004009586A1 (fr) * 2002-07-19 2004-01-29 Biovitrum Ab Nouveaux derives de piperazinyl-pyrazinone pour le traitement des troubles lies au recepteur 5-ht2a
SE0202287D0 (sv) * 2002-07-19 2002-07-19 Biovitrum Ab New compounds
AU2004221812B2 (en) 2003-03-19 2010-02-18 Exelixis Inc. Tie-2 modulators and methods of use
MXPA06003578A (es) * 2003-09-30 2006-08-31 Johnson & Johnson Compuestos de quinoxalina.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL260335A (fr) * 1960-01-22
CH450434A (de) * 1961-12-14 1968-01-31 Ciba Geigy Verfahren zur Herstellung von Diazinen
BE788451A (fr) * 1971-09-08 1973-03-06 Bayer Ag Nouvelles 2-amino-quinoxalines, leur procede de preparation et leur application comme insecticides, acaricides et fongicides
GB1457400A (en) * 1972-11-20 1976-12-01 Pfizer Pharmaceutical compositions containing 2-substituted quinoxa lines

Also Published As

Publication number Publication date
AU7073174A (en) 1976-01-08
NL7408705A (nl) 1975-01-15
RO63539A (fr) 1978-07-15
ES428107A1 (es) 1976-11-16
SE417316B (sv) 1981-03-09
IE39869L (en) 1975-01-13
JPS5037791A (fr) 1975-04-08
DD112127A5 (fr) 1975-03-20
NO742351L (fr) 1975-02-10
IL45158A0 (en) 1974-11-29
GB1440722A (en) 1976-06-23
FR2236499B1 (fr) 1977-04-15
CH605919A5 (fr) 1978-10-13
DE2433397A1 (de) 1975-02-06
LU70510A1 (fr) 1975-03-27
FI193974A (fr) 1975-01-14
SE7408486L (sv) 1975-01-14
BG21606A3 (fr) 1976-07-20
FR2236499A1 (fr) 1975-02-07
DK342674A (fr) 1975-03-03

Similar Documents

Publication Publication Date Title
IE39869B1 (en) 2-(1'-piperazinyl)-quinoxaline compounds having pharmaceutical activity
IL118889A0 (en) N-(aroyl) glycine hydroxamic acid derivatives and related compounds
NZ504203A (en) Pleuromutilin derivatives as antimicrobials
GB1457078A (en) Pyrazolo pyridine derivatives
EP0326307A3 (en) Novel pyridazinone derivatives and pharmaceutical preparations containing them
IL26473A (en) 4,1-Bis- (4-pyrimidylamino-alkyl) piperazines and process for their production
GB1530412A (en) Pyrimidinylureas
GB1476698A (en) Quinazolinone derivatives and therapeutic compositions containing them
DE69223769D1 (en) Diphenylylchinuclidine als squalen-synthetase-inhibitoren
GB1449861A (en) Benzodiazepine and benzodiazocine derivatives
GB1299151A (en) 7-phenylpyrimido-benzodiazepine derivatives
US3784693A (en) 3-substituted phenyl-quinazoline-4(3h)-ones as sedative hypnotics
GB1361368A (en) Pyrido 4,3-c pyridazine compounds
GB1515063A (en) Antibacterial quinoxaline 1,4-dioxides
DE3666588D1 (en) Spiroûbenzofuran-2(3h), 1'cycloheptane¨s, a process and intermediates for their preparation and their use as medicaments
GB1334125A (en) Aminopropionanilides and a process for the preparation thereof
GB1325280A (en) 3-substituted-as-triazino-5,6-c-quinolines
GB1327552A (en) 1-substituted benzyl tetrahydro-2-1h-pyrimidones and their preparation
IE42230L (en) Pharmaceutical combination preparation
GB1505859A (en) Azetidinone derivatives
GB1426978A (en) Pyrazolodiazocine compounds and methods for their production
EP0919233B8 (fr) Agent therapeutique contre les maladies renales
GB1438180A (en) 1,2,4-benzotriazine derivatives their production and their pharmaceutical and veterinary use
GB1497827A (en) Triazolobenzodiazepine derivatives
GB1307202A (en) Quinazoline derivative a process for producing them and compositions containing them